English - Siegfried

More documents

Recommendations

Info

as far as safety goes. There is room for improvement in ourenvironmental performance, although we are somewhatconstrained by our product mix.I have had the privilege of working the past ten years atSiegfried and the one constant, aside from acceleratedchange, is that substance matters. This substance includesthe institutional knowledge acquired and documentedby our employees over our 133 year history and the trustand collaborative spirit we’ve built up with our customers.My heartfelt thanks go to all Siegfried employees world -wide for helping us be a valued partner.Douglas C. GünthardtCEOAnnual Report13
The Siegfried Division PipelineThe Siegfried Division pipeline consists of three stages; anexplanation by business unit is given below.Business Unit Siegfried Actives/Custom synthesis:These projects follow the classic system of clinical studies(pre-clinical, clinical study phases I – III). Stage 1 of thepipeline includes projects that are either pre-clinical or clinicalstudy phase I. Phase II and III are stage 2 in the pipeline.Time and again, Siegfried receives active pharmaceuticalingredients projects that have already been launched in themarket, especially when the customer has insufficientproduction capacity or prefers to outsource productioncompletely; these projects are stage 3 in our pipeline.Business Unit Siegfried Actives/Multi-client-products:These projects are for internally developed out of patentactive pharmaceutical ingredients that can be offered tonumerous customers. In the U.S. these are usually controlledsubstances, where the Drug Enforcement Agency (DEA)closely monitors production and distribution. These projects
Page 1 and 2: Siegfried - when substance mattersA
Page 3 and 4: OverviewFor 2006, the Siegfried Gro
Page 6 and 7: Sabrina BaumannChemical Lab Apprent
Page 8 and 9: custom synthesis and shorten projec
Page 10: we are obligated to maintain our in
Page 13 and 14: Annual ReportThe Siegfried Division
Page 15: apid change as significant price er
Page 19 and 20: The Sidroga DivisionThe Sidroga Div
Page 21 and 22: OutlookThe revenues for active phar
Page 23 and 24: Board of Directors and Corporate Of
Page 26 and 27: Adrian AzzopardiQuality Control Man
Page 28 and 29: 2. Foreword and general frameworkRe
Page 30 and 31: 3.2 Participation structure of Sieg
Page 32 and 33: 4.2 CrossholdingsThe Siegfried Grou
Page 34 and 35: 6.2 ProfilesDr Markus Altwegg, Chai
Page 36 and 37: Prof Dr med Felix GutzwillerFelix G
Page 38 and 39: 6.3 Linking directorates6.3.1 Corpo
Page 40 and 41: Excerpt from the company regulation
Page 42 and 43: 7.2 ProfilesDouglas C. Günthardt,
Page 44 and 45: 7.3 Management ContractsSiegfried H
Page 46 and 47: 9.3 Calling a General Meeting of Sh
Page 48: 12. Information policyThe Siegfried
Page 51 and 52: Report on“Safety - Health - Envir
Page 53 and 54: Overview 2002-2006Key corporate fig
Page 55 and 56: Resources2002-2006 overviewUnit 200
Page 57 and 58: Workplace accidentsComparison: 2002
Page 60 and 61: Paul GauvreauProcess Development Ch
Page 62 and 63: Net profits declined from CHF 36.5
Page 64 and 65: Consolidated Income Statementfor th
Page 66 and 67:
Consolidated Statement of Recognize
Page 68 and 69:
Restated Recognized Income and Expe
Page 70 and 71:
asset in question is reviewed and,
Page 72 and 73:
Research and development Research a
Page 74 and 75:
Financial Statements Siegfried Grou
Page 76 and 77:
2. Property, plant and equipmentIn
Page 78 and 79:
The recoverability of capitalized G
Page 80 and 81:
8. Other current assetsIn 1000 CHF
Page 82 and 83:
The financial liabilities are denom
Page 84 and 85:
The following amounts are recognize
Page 86 and 87:
Contingent liabilities for addition
Page 88 and 89:
Report of the Group auditorsto the
Page 90:
Financial Statements Siegfried Grou
Page 93 and 94:
Financial Statements Siegfried Hold
Page 95 and 96:
Securities are stated at the lower
Page 97 and 98:
Stock market data2006 2005 2004 200
Page 99 and 100:
Cautionary statement regarding forw
show all

English - Siegfried

Create successful ePaper yourself

Delete template?

Save as template?